| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.03 |